Plain-English translation of NCT07056374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new surgical device called the C-REX RectoAid Cath that surgeons use to reconnect the bowel after removing cancer from the lower colon or upper rectum. Instead of using traditional stapling methods, this device creates a special connection by locking two silicone rings together, which may reduce complications and improve healing. The study will follow 165 patients who receive this surgery to see how well it works and how safe it is.
Standard bowel surgery uses stapling devices that have been around for many years, but surgeons believe a newer connection technique might result in better outcomes with fewer complications. This trial will help doctors understand whether this new device is a safer and more effective option for patients needing surgery to remove colon and rectal cancers.
You likely qualify if…
You likely don't qualify if…
If you are selected for this trial, you will undergo the planned surgical removal of your cancerous bowel segment using the new C-REX RectoAid Cath device to reconnect your bowel. Your surgeon will have received special training to use this device. You will need to prepare your bowel before surgery with standard bowel cleansing, and after surgery you will be followed to monitor how well the connection heals and how you recover.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Netherlands